1703752-99-1
1703752-99-1
Chemical Structure
p-SCN-Bn-DOTA(tBu)4
- CAS. Nr.: 1703752-99-1
- Formula:C40H65N5O8S
- Molecular Weight:776.04
InChIKey: CPECBRYFWCACRP-UHFFFAOYSA-N
SMILES: O=C(CN1CCN(CCN(C(CN(CC1)CC(OC(C)(C)C)=O)CC2=CC=C(C=C2)N=C=S)CC(OC(C)(C)C)=O)CC(OC(C)(C)C)=O)OC(C)(C)C
Biological Activity: p-SCN-Bn-DOTA(tBu)4 is the derivative of DOTA (HY-W053583). p-SCN-Bn-DOTA(tBu)4 is the component of the Gd(III)-DOTA-IAC, which is a targeted magnetic resonance imaging (MRI) contrast agent for αvβ3 integrin receptor[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
p-SCN-Bn-DOTA(tBu)4 | p-SCN-Bn-DOTA(tBu)4 is the derivative of DOTA (HY-W053583). p-SCN-Bn-DOTA(tBu)4 is the component of the Gd(III)-DOTA-IAC, which is a targeted magnetic resonance imaging (MRI) contrast agent for αvβ3 integrin receptor. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
